251 related articles for article (PubMed ID: 18795111)
1. CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents.
Srivastava V; Kumar A; Mishra BN; Siddiqi MI
Bioinformation; 2008 Jun; 2(9):384-91. PubMed ID: 18795111
[TBL] [Abstract][Full Text] [Related]
2. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
3. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
[TBL] [Abstract][Full Text] [Related]
4. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
Gade S; Mahmood S
J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
Patel PD; Patel MR; Kaushik-Basu N; Talele TT
J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
[TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
7. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
[TBL] [Abstract][Full Text] [Related]
9. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
Doddareddy MR; Cho YS; Koh HY; Pae AN
Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.
Saqib U; Siddiqi MI
SAR QSAR Environ Res; 2009 Jul; 20(5-6):519-35. PubMed ID: 19916112
[TBL] [Abstract][Full Text] [Related]
11. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
12. Prediction of octanol-air partition coefficients for polychlorinated biphenyls (PCBs) using 3D-QSAR models.
Chen Y; Cai X; Jiang L; Li Y
Ecotoxicol Environ Saf; 2016 Feb; 124():202-212. PubMed ID: 26524653
[TBL] [Abstract][Full Text] [Related]
13. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
Gunda SK; Narasimha SK; Shaik M
Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists.
Aher YD; Agrawal A; Bharatam PV; Garg P
J Mol Model; 2007 Apr; 13(4):519-29. PubMed ID: 17345108
[TBL] [Abstract][Full Text] [Related]
15. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.
Wu HQ; Yao J; He QQ; Chen FE
SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254
[TBL] [Abstract][Full Text] [Related]
16. Ligand-based CoMFA and CoMSIA studies on chromone derivatives as radical scavengers.
Phosrithong N; Ungwitayatorn J
Bioorg Chem; 2013 Aug; 49():9-15. PubMed ID: 23838011
[TBL] [Abstract][Full Text] [Related]
17. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
18. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
Xu HR; Fu L; Zhan P; Liu XY
SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
[TBL] [Abstract][Full Text] [Related]
19. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors.
Ul-Haq Z; Wadood A; Uddin R
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):272-8. PubMed ID: 18608766
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR CoMFA/CoMSIA and docking studies on azole dione derivatives, as anti-cancer inhibitors.
Anugolu RK; Gunda SK; Mahmood S
Int J Comput Biol Drug Des; 2012; 5(2):111-36. PubMed ID: 22854121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]